Cardiff Oncology (CRDF) SEC Filings & 10K Form

$4.07
+0.08 (+2.01%)
(As of 04:27 PM ET)

Recent Cardiff Oncology SEC Filings

DateFilerForm TypeView
03/07/2024
5:39 PM
Cardiff Oncology, Inc. (Issuer)
Cardiff Oncology (Issuer)
Erlander Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
5:39 PM
Cardiff Oncology, Inc. (Issuer)
Cardiff Oncology (Issuer)
Smeal Tod (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
5:40 PM
Cardiff Oncology, Inc. (Issuer)
Cardiff Oncology (Issuer)
Kabbinavar Fairooz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
5:40 PM
Cardiff Oncology, Inc. (Issuer)
Cardiff Oncology (Issuer)
Levine James E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:08 PM
Cardiff Oncology, Inc. (Filer)
Cardiff Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/29/2024
3:00 PM
Cardiff Oncology, Inc. (Filer)
Cardiff Oncology (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
01/08/2024
8:12 AM
Cardiff Oncology, Inc. (Filer)
Cardiff Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2023
5:39 PM
Cardiff Oncology, Inc. (Issuer)
Cardiff Oncology (Issuer)
PACE GARY W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2023
4:13 PM
Cardiff Oncology, Inc. (Filer)
Cardiff Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2023
4:24 PM
Cardiff Oncology, Inc. (Filer)
Cardiff Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2023
4:04 PM
Cardiff Oncology, Inc. (Issuer)
Cardiff Oncology (Issuer)
PACE GARY W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
4:05 PM
Cardiff Oncology, Inc. (Issuer)
Cardiff Oncology (Issuer)
White Lale (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
4:06 PM
Armitage James O (Reporting)
Cardiff Oncology, Inc. (Issuer)
Cardiff Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
4:08 PM
Cardiff Oncology, Inc. (Issuer)
Cardiff Oncology (Issuer)
Markin Rodney S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2023
3:45 PM
Cardiff Oncology, Inc. (Filer)
Cardiff Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:CRDF) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners